BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 22877736)

  • 21. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
    Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
    Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.
    Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T
    Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus?
    von Rahden BH; Kircher S; Lazariotou M; Reiber C; Stuermer L; Otto C; Germer CT; Grimm M
    J Exp Clin Cancer Res; 2011 Feb; 30(1):23. PubMed ID: 21345220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.
    Cai JC; Liu D; Liu KH; Zhang HP; Zhong S; Xia NS
    World J Gastroenterol; 2008 Jul; 14(25):4070-6. PubMed ID: 18609693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
    Grady WM; Yu M
    Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
    Fichter CD; Timme S; Braun JA; Gudernatsch V; Schöpflin A; Bogatyreva L; Geddert H; Faller G; Klimstra D; Tang L; Hauschke D; Werner M; Lassmann S
    Int J Cancer; 2014 Oct; 135(7):1517-30. PubMed ID: 24510732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.
    Yoon HH; Shi Q; Sukov WR; Wiktor AE; Khan M; Sattler CA; Grothey A; Wu TT; Diasio RB; Jenkins RB; Sinicrope FA
    Clin Cancer Res; 2012 Jan; 18(2):546-54. PubMed ID: 22252257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
    Feith M; Stein HJ; Mueller J; Siewert JR
    Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus.
    Bonde P; Gao D; Chen L; Duncan M; Miyashita T; Montgomery E; Harmon JW; Wei C
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):74-81. PubMed ID: 17198784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
    Probst A; Aust D; Märkl B; Anthuber M; Messmann H
    Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.
    van Nistelrooij AM; van Marion R; Koppert LB; Biermann K; Spaander MC; Tilanus HW; van Lanschot JJ; Wijnhoven BP; Dinjens WN
    BMC Res Notes; 2017 Apr; 10(1):144. PubMed ID: 28376920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genomic alterations in oesophageal squamous cell cancer.
    Song Y; Li L; Ou Y; Gao Z; Li E; Li X; Zhang W; Wang J; Xu L; Zhou Y; Ma X; Liu L; Zhao Z; Huang X; Fan J; Dong L; Chen G; Ma L; Yang J; Chen L; He M; Li M; Zhuang X; Huang K; Qiu K; Yin G; Guo G; Feng Q; Chen P; Wu Z; Wu J; Ma L; Zhao J; Luo L; Fu M; Xu B; Chen B; Li Y; Tong T; Wang M; Liu Z; Lin D; Zhang X; Yang H; Wang J; Zhan Q
    Nature; 2014 May; 509(7498):91-5. PubMed ID: 24670651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
    Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma.
    van Baal JW; Milana F; Rygiel AM; Sondermeijer CM; Spek CA; Bergman JJ; Peppelenbosch MP; Krishnadath KK
    Cell Oncol; 2008; 30(1):63-75. PubMed ID: 18219111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.
    Naritaka Y; Ogawa K; Shimakawa T; Wagatsuma Y; Isohata N; Asaka S; Miyaki A; Shiozawa S; Katsube T; Yoshimatsu K; Aiba M; Ide H
    Anticancer Res; 2007; 27(1B):505-11. PubMed ID: 17348434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
    Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
    Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.